Giant drugmaker Johnson & Johnson has agreed to buy Dutch vaccine maker Crucell. The deal will give J&J a bigger piece of the vaccine market and better access to emerging markets.
Continue reading J&J to Acquire Vaccine Maker Crucell
J&J to Acquire Vaccine Maker Crucell originally appeared on DailyFinance on Wed, 06 Oct 2010 08:10:00.
Filed Under: Company News, Johnson & Johnson, Stocks in the News